Home
About
Publications Trends
Recent Publications
Expert Search
Archive
yellow fever vaccine associated neurotropic disease (yel and)
What is YEL-AND?
YEL-AND is a rare but potentially severe adverse event following the administration of the
yellow fever vaccine
. It manifests as a range of neurological symptoms, from mild headaches and fever to more severe conditions such as
encephalitis
,
meningoencephalitis
, or
Guillain-Barré syndrome
. The condition typically arises within 30 days post-vaccination.
Frequently asked queries:
What is YEL-AND?
What is Stratification in Epidemiology?
What is Maternal Age?
What are Health Registries?
What is Data Cleaning?
How Does EWARS Work?
How important is community involvement in rural health initiatives?
What are the Limitations of Incidence Density?
How to Prepare for an Academic Career in Epidemiology?
Why is Primary Prevention Important?
What is Discrimination in Epidemiology?
What is the Importance of Training and Education for Healthcare Providers?
What Role Do Influencers Play in Health Communication?
How can we prevent Multifactorial Conditions?
What is Model Fitting in Epidemiology?
What are Prophylactic Measures?
What role do social determinants of health play in drug trafficking?
How Does Urban Design Affect Public Health?
How is the Skin Prick Test Performed?
Why is Vector Control Important?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Andes Virus
COVID-19 Patients
Field Epidemiology
Genetic Diagnosis
Genetic Variants
Global Health
Public Health Education
Partnered Content Networks
Relevant Topics
active learning
African Populations
Andes virus
APOL1
arrhythmias
blended learning
cardiac complications
Chronic Kidney Disease
COVID-19
Disease Prevention
disease surveillance
emerging diseases
epidemiology
Epidemiology Training Laboratory Diagnostics
Evolutionary Genetics
experiential learning
Field Epidemiology
Field Epidemiology Training Programs
fieldwork
FSGS
genetic counseling
genetic testing
Genetic Variants
global disease monitoring
Global Health Capacity
Global health security
Global Health Security Agenda
H-ESKD
hantavirus
hantavirus pulmonary syndrome
Health Security
heart failure
hereditary paragangliomas
HIF pathway
human-to-human transmission
infectious diseases
internships
Kidney Disease
laboratory networks
Laboratory Training Programs
myocardial injury
myocarditis
Outbreak Investigation
outbreak response
pedagogy
person-to-person transmission
pseudo-hypoxia
Public Health
Public health education
public health infrastructure
public health practice
public health strategies
Public Health Workforce
renal cell carcinoma
respiratory transmission
SDH mutations
Surveillance Systems
technology in education
thromboembolism
tumorigenesis
viral outbreaks
zoonotic diseases
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Epidemiology.
Subscribe